Ariceum Therapeutics
PrivateLast Round
Series A
Extension
Apr 18, 2023
Total Funding Raised
$51.73M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Ariceum Therapeutics is a biotechnology company that develops targeted radiopharmaceutical therapies for the diagnosis and treatment of aggressive and hard-to-treat cancers.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ariceum Therapeutics Comparables
Compare Ariceum Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Alpha-9 Oncology | 83% | |
| ARTBIO | 81% | |
| Convergent Therapeutics | 77% | |
Ariceum Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Apr 18, 2023 | ||||
| Series A | Jun 8, 2022 |
Key People
Founding team and executive leadership
Ariceum Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| EQT Life Sciences | Series A |
| Andera Partners | Series A Extension |
| HealthCap | Series A |
| Pureos Bioventures | Series A Extension, Series A |
| Earlybird Venture Capital | Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 19, 2026
Monthly visitors grew 150% MoM, from 258 to 646.
- Oct 14, 2025
ATT001, a novel radiolabeled I-123 PARP inhibitor, is in development.
Ariceum Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Ariceum Therapeutics's valuation, stock price, and market status.